The Game-Changing MS Study | Mary Chapman & Dr. Saidha

In this enlightening installment of Free Thinking with Montel, we delve into a pivotal moment in the battle against Multiple Sclerosis (MS), a condition that impacts millions worldwide, including our host Montel Williams. In this episode we will explore a revolutionary new study on remyelination, which could potentially transform the treatment and management of MS.

First, we sit down with Mary Chapman, a 25-year MS survivor and passionate patient advocate. Mary shares her deeply personal journey, from her initial diagnosis and the challenges she faced to becoming a resilient fighter and advocate for MS awareness. Her story is one of perseverance, strength, and hope, offering inspiration to many who face similar battles.

Following Mary’s compelling narrative, we welcome Dr. Shiv Saidha from the Johns Hopkins Multiple Sclerosis Center. Dr. Saidha is at the forefront of MS research, and he provides an in-depth look at the basics of MS, the significance of remyelination, and the groundbreaking study he is spearheading. This study aims to develop new treatment options that could drastically improve the quality of life for those living with MS.

Dr. Saidha elaborates on the unique goals and innovative techniques of his research, highlighting the critical role of private philanthropy in advancing scientific breakthroughs. He explains why traditional grant funding falls short for such pioneering endeavors and discusses the biggest hurdles in identifying effective treatments for MS.

Together, Mary and Dr. Saidha reflect on the importance of this research and its potential to bring hope to the 2.8 million people affected by MS worldwide. They also share their vision for the future of MS treatment and patient care over the next decade.

This research is a beacon of hope for everyone affected by MS.

Support Mary's Campaign to Unlock Nerve Repair in MS

 https://aspire.hopkinsmedicine.org/project/40589

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.